185 related articles for article (PubMed ID: 33259133)
1. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
Jiang W; Zhu D; Wang C; Zhu Y
Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
[TBL] [Abstract][Full Text] [Related]
2. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway.
Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J
J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286
[TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.
Berglund AE; Scott KE; Li W; Yang C; Fernandez MR; Schaub FX; Cleveland JL; Rounbehler RJ
Oncotarget; 2016 Dec; 7(50):83462-83475. PubMed ID: 27825143
[TBL] [Abstract][Full Text] [Related]
5. circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis.
Tan S; Kang Y; Li H; He HQ; Zheng L; Wu SQ; Ai K; Zhang L; Xu R; Zhang XZ; Zhao XK; Zhu X
Cell Death Dis; 2021 Feb; 12(2):168. PubMed ID: 33568625
[TBL] [Abstract][Full Text] [Related]
6. Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression.
Wang C; Ge Q; Chen Z; Hu J; Li F; Ye Z
Tumour Biol; 2016 May; 37(5):6589-98. PubMed ID: 26643891
[TBL] [Abstract][Full Text] [Related]
7. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1.
Tian Z; Cao S; Li C; Xu M; Wei H; Yang H; Sun Q; Ren Q; Zhang L
J Cell Physiol; 2019 Apr; 234(4):4799-4811. PubMed ID: 30317572
[TBL] [Abstract][Full Text] [Related]
9. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
[TBL] [Abstract][Full Text] [Related]
11. Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis.
Fan L; Yang J; Shen C; Wu Z; Hu H
Acta Histochem; 2021 Jul; 123(5):151745. PubMed ID: 34175686
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7.
Zhang J; Mao S; Wang L; Zhang W; Zhang Z; Guo Y; Wu Y; Yi F; Yao X
Oncol Rep; 2019 Feb; 41(2):819-828. PubMed ID: 30483807
[TBL] [Abstract][Full Text] [Related]
13. Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.
Wang C; Ge Q; Zhang Q; Chen Z; Hu J; Li F; Ye Z
J Exp Clin Cancer Res; 2016 Mar; 35():53. PubMed ID: 27012825
[TBL] [Abstract][Full Text] [Related]
14. Aberrant FBXW7-mediated ubiquitination and degradation of ZMYND8 enhances tumor progression and stemness in bladder cancer.
Qiu F; Jin Y; Pu J; Huang Y; Hou J; Zhao X; Lu Y
Exp Cell Res; 2021 Oct; 407(2):112807. PubMed ID: 34487730
[TBL] [Abstract][Full Text] [Related]
15. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.
Chen JX; Chen DM; Wang D; Xiao Y; Zhu S; Xu XL
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960869
[TBL] [Abstract][Full Text] [Related]
16. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
Meng L; Xing Z; Guo Z; Liu Z
Cell Death Dis; 2020 Dec; 11(12):1063. PubMed ID: 33311496
[TBL] [Abstract][Full Text] [Related]
17. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
20. Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin.
Lee HH; Vo MT; Kim HJ; Lee UH; Kim CW; Kim HK; Ko MS; Lee WH; Cha SJ; Min YJ; Choi DH; Suh HS; Lee BJ; Park JW; Cho WJ
J Biol Chem; 2010 Jun; 285(23):17329-37. PubMed ID: 20335167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
